Company: IPCX
Filing Date: 2025-04-25
Form Type: 424B4
Source: 0001213900-25-035659
Chunk: 270

Company: Inflection Point Acquisition Corp. III
Filing Date: 2025-04-25
Form: 424B4
Chunk 270
---
 Underlying Securities |     | No Transfer until 30 days after the completion of our initial business combination. |     | Our sponsor, officers, directors, director nominees, other initial shareholders and Cantor Fitzgerald & Co. |     | Same as above (other than clause (g) with respect to the inclusion of Cantor Fitzgerald & Co.).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

Pursuant to the letter agreement, for the benefit of Cantor Fitzgerald & Co., our sponsor and management team also agreed that, for a period of 180 days from the date of this prospectus, they will not, without the prior written consent of Cantor Fitzgerald & Co., offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, any Class A ordinary shares or any other securities convertible into, or exercisable, or exchangeable for, Class A ordinary shares, subject to customary exceptions. Cantor Fitzgerald & Co. in its sole discretion may release any of the securities subject to these lock -upagreements at any time without notice. The letter agreement also provides that our sponsor and management team agree to vote any founder shares, private placement shares included in private placement units and any public shares they may own in favor of a proposed initial business combination if we seek shareholder approval for such business combination (except with respect to any public shares which may not be voted in favor of approving the business combination transaction in accordance with the requirements of Rule 14e -5under the Exchange Act and any SEC interpretations or guidance relating thereto) and in favor of any proposals recommended by our board of directors in connection with such business combination. Further, our sponsor and management team also agreed not to redeem any public shares they may hold in connection with such shareholder approval. The letter agreement may not be changed, amended, modified or waived as to any particular provision, except by a written instrument executed by (i) each individual signatory to the letter agreement with respect to herself or himself, as applicable, to the extent she or he are the subject of any such change, amendment, modification or waiver, (ii) us, and (iii) our sponsor. Pursuant to the underwriting agreement, we agreed to not amend, modify or otherwise change the letter agreement without the prior written consent of Cantor Fitzgerald & Co., which will not be unreasonably delayed, conditioned or withheld. While we do not expect our board to approve any amendment to the letter agreement prior to our initial business combination, it may be possible that our board, in exercising its